Suchen
Merck & Co Inc
MRKZur Watchlist hinzufügen
144.330USD
+0.400+0.28%
Trading geöffnet 09/14, 10:44（ET）
356.30BMarktkapitalisierung
40.46KGV TTM
mehr Informationen über Merck & Co Inc Unternehmen
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Merck & Co Inc Profil
BörsenkürzelMRK
Name des UnternehmensMerck & Co Inc
IPO-datumFeb 06, 2077
CEODavis (Robert M)
Anzahl der mitarbeiter75000
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 06
Addresse126 East Lincoln Avenue
StadtRAHWAY
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07065
Telefon19087404000
Websitehttps://www.merck.com/
BörsenkürzelMRK
IPO-datumFeb 06, 2077
CEODavis (Robert M)
Führungskräfte von Merck & Co Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Executive Vice President - Strategic Access, Policy & Communications
Executive Vice President - Strategic Access, Policy & Communications
31.20K
-80.12%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Executive Vice President - Strategic Access, Policy & Communications
Executive Vice President - Strategic Access, Policy & Communications
31.20K
-80.12%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+19.93%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
450.35K
+1.50%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
200.68K
+0.73%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
94.43K
+2.54%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
45.02K
-56.39%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Merck & Co Inc?
Die fünf größten Anteilseigner von Merck & Co Inc sind: Mr. Robert M. (Rob) Davis
Wie viele Institutionen halten Anteile an Merck & Co Inc (MRK)?
Mit Stand vom 2026Q1 halten 5687 Institutionen Anteile an Merck & Co Inc, mit einem Gesamtmarktwert von etwa 2.01B, was 81.41% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10595247.00 gestiegen.
Was ist die größte Einnahmequelle von Merck & Co Inc?
Am 2026Q1 erzielte das Geschäft mit Oncology-Keytruda für Merck & Co Inc den höchsten Umsatz in Höhe von 7.90B, was 47.59% des Gesamtumsatzes entspricht.